发明名称
摘要 PROBLEM TO BE SOLVED: To provide poxvirus particles that are very useful in treatment for gene therapy, particularly in prophylaxis and therapy for mammalian cancers. SOLUTION: The objective poxvirus particles have the targeted infection specificity that is given by a heteroligand part that specifically recognizes and binds to the antiligand molecule locating itself on the surface of the target cells on the poxvirus particle surfaces. Further, this invention provide a vector including the nucleotide sequence encoding the chimera polypeptide including the heteroligand part and all of or a part of the surface polypeptides on the natural type poxvirus particles. In addition, this invention relates to a composition including these poxvirus particles or this vector.
申请公布号 JP4802401(B2) 申请公布日期 2011.10.26
申请号 JP20010179289 申请日期 2001.06.13
申请人 发明人
分类号 C12N15/09;A61K35/76;A61K48/00;A61P35/00;C07K1/22;C12N7/00;C12R1/93 主分类号 C12N15/09
代理机构 代理人
主权项
地址